Vizient, Inc. Applauds FDA’s Heightened Focus on Preventing Drug Shortages

10:51 EDT 13 Jul 2018 | Businesswire

This article has expired, however you can still download the PDF.
Vizient, Inc. applauds the U.S. Food and Drug Administration (FDA) for forming a new drug shortages task force and advancing long-term solutions to prevent shortages. Stable and reliable supply, along with cost a...

Other Sources for this Article

Vizient, Inc.
Angie Boliver, 972-830-7961


More From BioPortfolio on "Vizient, Inc. Applauds FDA’s Heightened Focus on Preventing Drug Shortages"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...